Physician profile
Anthony M Simone
NPI 1194188581
$611.47
in general payments reported to CMS, 2019-2025
8 companies · $419 in 2025
The $419 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $130 · 2024: $63.00 · 2025: $419.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $611.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $611.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $172.01 | 2025 | Aveir |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $133.14 | 2024-2025 | Lifevest |
| Esperion Therapeutics, INC. | $129.72 | 2023 | Nexlizet, Nexletol |
| Boston Scientific Corporation | $61.70 | 2024-2025 | Watchman Flx, Bodyguardian |
| Heartflow, INC. | $54.35 | 2025 | |
| Pfizer INC. | $23.67 | 2025 | |
| Impulse Dynamics (USA) INC. | $18.54 | 2025 | Optimizer |
| Medtronic, INC. | $18.34 | 2025 | Linq II |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Simone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.